Flosulide
Alternative Names: CGP 28238; CGS 28238; SH 459; ZK 38997Latest Information Update: 03 Sep 2002
Price :
$50 *
At a glance
- Originator Bayer Schering Pharma
- Developer Imperial Innovations
- Class Antirheumatics; Indans; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Preterm labour; Rheumatic disorders